The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

Until now, the drugs have only been available from specialist NHS clinics or private pharmacies, costing around £150 to £200 ...